European Health Policy and the Prevention of Cardiometabolic Multiple Long-Term Conditions
A blended intensive elective on European health policy and the prevention of cardiometabolic multiple long-term conditions — the overlapping spectrum of heart failure, atrial fibrillation, chronic kidney disease, type 2 diabetes, hypertension, hypercholesterolaemia, obesity as it relates to cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease. Alternative labels in current use include CKM, CVKM, CVRM, CKLM and DCRM.
The course combines European Union health policy with current clinical practice, AI-enabled risk assessment and precision prevention; lifestyle and behaviour change runs through all four themes.
We will teach this elective in Georgia in November 2026 and, on proposed dates, in March–April 2027. Each delivery has four thematic units taught by live webinar, followed by one on-campus week.
Cardiometabolic
European Health Policy and the Prevention of Cardiometabolic Multiple Long-Term Conditions
Cardiometabolic
European Health Policy and the Prevention of Cardiometabolic Multiple Long-Term Conditions
Learning outcomes
Cardiometabolic · 6 ECTS · November 2026
We will teach this delivery in Georgia in November 2026. Live webinars Tue 27 Oct – Sat 21 Nov 2026 (Tuesdays 16:00–19:00 and Saturdays 16:00–20:00, Georgia time); on campus Tue 24 – Sat 28 Nov 2026. Workload 180 hours: 60 h taught, 6 h examinations, 114 h independent study; 22 h of the taught programme is European Union policy teaching. Up to 30 students.
| Unit | Date · Georgia time · UK time | Session |
|---|---|---|
| Unit 1 | Tue 27 Oct 2026 16:00–19:00 Georgia 12:00–15:00 GMT | AI and digital health policy for cardiometabolic risk stratification Lecture (3 h): how the European Union makes health policy; the AI Act, European Health Data Space and Medical Device Regulation in cardiometabolic risk prediction. |
| Unit 1 | Sat 31 Oct 2026 16:00–20:00 Georgia 12:00–16:00 GMT | AI and digital health policy for cardiometabolic risk stratification Working group (4 h, with 30-min policy-to-practice segment): risk stratification in practice using European and comparator risk tools, staging, biomarkers and wearables. Formative self-assessment quiz (15 questions with worked answers; not graded). |
| Unit 2 | Tue 3 Nov 2026 16:00–19:00 Georgia 12:00–15:00 GMT | Heart failure and chronic kidney disease Lecture (3 h): early detection and inequalities under the EU Cardiovascular Health Plan and the proposed Council Recommendation on cardiovascular health checks. |
| Unit 2 | Sat 7 Nov 2026 16:00–20:00 Georgia 12:00–16:00 GMT | Heart failure and chronic kidney disease Working group: the 2026 ESC guidelines on heart failure, and on cardiovascular disease and chronic kidney disease; guideline-directed therapy and cardiorenal protection. Formative self-assessment quiz (15 questions with worked answers; not graded). |
| Unit 3 | Tue 10 Nov 2026 16:00–19:00 Georgia 12:00–15:00 GMT | Hypertension and lipid management Lecture (3 h): European prevention policy for blood pressure and lipids; national cardiovascular plans and targets. |
| Unit 3 | Sat 14 Nov 2026 16:00–20:00 Georgia 12:00–16:00 GMT | Hypertension and lipid management Working group: measurement, targets, combination therapy and intensification of lipid lowering. Formative self-assessment quiz (15 questions with worked answers; not graded). |
| Unit 4 | Tue 17 Nov 2026 16:00–19:00 Georgia 12:00–15:00 GMT | Type 2 diabetes and obesity Lecture (3 h): health technology assessment and access to medicines in Europe, with NICE TA1152 as a United Kingdom comparator. |
| Unit 4 | Sat 21 Nov 2026 16:00–20:00 Georgia 12:00–16:00 GMT | Type 2 diabetes and obesity Working group: therapies with cardiovascular and kidney benefit; obesity care; steatotic liver disease; lifestyle and behaviour change. Formative self-assessment quiz (15 questions with worked answers; not graded). |
| Exam | Sun 22 Nov 2026 22:00 Georgia 18:00 GMT | Mid-term examination Online: 60 single-best-answer questions, 120 minutes. 60 points. |
| Note | Mon 23 Nov 2026 | Monday 23 November 2026 is a public holiday in Georgia (St George’s Day): no teaching. |
| Campus | Tue 24 Nov 2026 Local campus hours UK = Georgia − 4 h | Unit 1 day 7-hour day: policy lecture (1.5 h), clinical lecture (2.5 h) and working group with a case-based practical class (3 h) including a case-based discussion with feedback. Theme: AI and risk stratification. |
| Deadline | Wed 25 Nov 2026 12:00 Georgia | Written capstone project 2,000 words; 5–10 references in Vancouver style; up to 4 tables and 4 figures. Submitted on the learning platform. |
| Campus | Wed 25 Nov 2026 Local campus hours UK = Georgia − 4 h | Unit 2 day 7-hour day as above, with a case-based discussion and feedback. Theme: heart failure and chronic kidney disease. Written capstone project due by 12:00. |
| Campus | Thu 26 Nov 2026 Local campus hours UK = Georgia − 4 h | Unit 3 day 7-hour day as above, with a case-based discussion and feedback. Theme: hypertension and lipid management. |
| Campus | Fri 27 Nov 2026 Local campus hours UK = Georgia − 4 h | Unit 4 day 7-hour day as above, with a case-based discussion and feedback. Theme: type 2 diabetes and obesity. |
| Campus | Sat 28 Nov 2026 Local campus hours UK = Georgia − 4 h | Capstone & oral presentation Capstone policy lecture (2 h) and small-group coaching (2 h) in the morning; oral presentation of the capstone project in the afternoon (4 h, two parallel panels). |
Cardiometabolic · 4 ECTS · March–April 2027
Proposed dates for March–April 2027. Live webinars Tue 16 Mar – Sat 10 Apr 2027 (Tuesdays 10:00–12:30 and Saturdays 10:00–13:30, Georgia time); on campus Mon 12 – Fri 16 Apr 2027. Workload 120 hours: 50 h taught, 4 h examinations, 66 h independent study; 20 h of the taught programme is European Union policy teaching. Up to 30 students.
| Unit | Date · Georgia time · UK time | Session |
|---|---|---|
| Unit 1 | Tue 16 Mar 2027 10:00–12:30 Georgia 06:00–08:30 GMT | AI and digital health policy for cardiometabolic risk stratification Lecture: how the European Union makes health policy; the AI Act, European Health Data Space and Medical Device Regulation in risk prediction. |
| Unit 1 | Sat 20 Mar 2027 10:00–13:30 Georgia 06:00–09:30 GMT | AI and digital health policy for cardiometabolic risk stratification Seminar: risk stratification in practice: risk scores, staging, biomarkers and wearables. Formative self-assessment quiz (15 questions with worked answers; not graded). |
| Unit 2 | Tue 23 Mar 2027 10:00–12:30 Georgia 06:00–08:30 GMT | Heart failure and chronic kidney disease Lecture: the EU Cardiovascular Health Plan: early detection, health checks and inequalities. |
| Unit 2 | Sat 27 Mar 2027 10:00–13:30 Georgia 06:00–09:30 GMT | Heart failure and chronic kidney disease Seminar: 2026 ESC guidelines, guideline-directed therapy and cardiorenal protection. Formative self-assessment quiz (15 questions with worked answers; not graded). |
| Unit 3 | Tue 30 Mar 2027 10:00–12:30 Georgia 07:00–09:30 BST | Hypertension and lipid management Lecture: European prevention policy, national cardiovascular plans and targets. |
| Unit 3 | Sat 3 Apr 2027 10:00–13:30 Georgia 07:00–10:30 BST | Hypertension and lipid management Seminar: blood pressure and lipid treatment to target. Formative self-assessment quiz (15 questions with worked answers; not graded). |
| Unit 4 | Tue 6 Apr 2027 10:00–12:30 Georgia 07:00–09:30 BST | Type 2 diabetes and obesity Lecture: health technology assessment and access to medicines in Europe. |
| Unit 4 | Sat 10 Apr 2027 10:00–13:30 Georgia 07:00–10:30 BST | Type 2 diabetes and obesity Seminar: therapies with cardiovascular and kidney benefit; obesity care; lifestyle and behaviour change. Formative self-assessment quiz (15 questions with worked answers; not graded). |
| Exam | Sun 11 Apr 2027 21:00 Georgia 18:00 BST | Mid-term examination Online: 40 single-best-answer questions, 60 minutes. 60 points. |
| Campus | Mon 12 Apr 2027 Local campus hours UK = Georgia − 3 h | Unit 1 day Policy lecture (1.5 h) and case-based group work (4.5 h): AI and risk stratification. |
| Campus | Tue 13 Apr 2027 Local campus hours UK = Georgia − 3 h | Unit 2 day Policy lecture (1.5 h) and case-based group work (4.5 h): heart failure and chronic kidney disease. |
| Deadline | Wed 14 Apr 2027 12:00 Georgia | Written capstone project 2,000 words; 5–10 references in Vancouver style; up to 4 tables and 4 figures. Submitted on the learning platform. |
| Campus | Wed 14 Apr 2027 Local campus hours UK = Georgia − 3 h | Unit 3 day Policy lecture (1.5 h) and case-based group work (4.5 h): hypertension and lipid management. Written capstone project due by 12:00. |
| Campus | Thu 15 Apr 2027 Local campus hours UK = Georgia − 3 h | Unit 4 day Policy lecture (1.5 h) and case-based group work (4.5 h): type 2 diabetes and obesity. |
| Campus | Fri 16 Apr 2027 Local campus hours UK = Georgia − 3 h | Capstone & oral presentation Capstone policy lecture (2 h) in the morning; oral presentation of the capstone project in the afternoon (3 h, two parallel panels). |
Four units, one integration week
AI and digital health policy for cardiometabolic risk stratification
Unit 1 · online week. Tuesday lecture on European policy; Saturday case-based session with a 30-minute policy-to-practice segment, followed by a self-assessment quiz with worked answers (not graded). The online mid-term examination follows on the Sunday of the fourth week.
Heart failure and chronic kidney disease
Unit 2 · online week. Tuesday lecture on European policy; Saturday case-based session with a 30-minute policy-to-practice segment, followed by a self-assessment quiz with worked answers (not graded). The online mid-term examination follows on the Sunday of the fourth week.
Hypertension and lipid management
Unit 3 · online week. Tuesday lecture on European policy; Saturday case-based session with a 30-minute policy-to-practice segment, followed by a self-assessment quiz with worked answers (not graded). The online mid-term examination follows on the Sunday of the fourth week.
Type 2 diabetes and obesity
Unit 4 · online week. Tuesday lecture on European policy; Saturday case-based session with a 30-minute policy-to-practice segment, followed by a self-assessment quiz with worked answers (not graded). The online mid-term examination follows on the Sunday of the fourth week.
Integration and the capstone project
On-campus week · Georgia. One theme per day in the order of Units 1–4; the written capstone project due on the Wednesday; the capstone policy lecture and the oral presentation on the final afternoon.
Methods of assessment — the same structure in every delivery
Two summative assessments in every elective, credit value and term: a 60-point mid-term examination at the end of the four webinar weeks, and the 40-point capstone project, submitted in writing and presented orally in the on-campus week. Weekly self-assessment quizzes support learning and are not graded.
| Component | What it involves | Weighting |
|---|---|---|
| Mid-term examination (summative) | Single-best-answer multiple-choice questions covering Weeks 1–4, sat online, on the secure learning platform (or the university’s Canvas or Moodle, to be confirmed) on the Sunday after the fourth week of webinars, at 18:00 UK time. At least 11 points are needed to sit the final assessment. | 60 points |
| Capstone project (summative) | An individual, policy-informed analysis of a clinical case, allocated from an anonymised case bank or, where available, an anonymised case from the student’s own clinical experience, benchmarked against a stated European objective (2,000 words; 5–10 references in Vancouver style; up to 4 tables and 4 figures). The written project is submitted on the learning platform by 12:00 on the Wednesday of the on-campus week (25 points) and presented to a faculty panel on the final afternoon — a 5-minute presentation followed by questions (15 points). | 40 points |
| Formative self-assessment (not graded) | At the end of each webinar week: 10 multiple-choice questions (WHEEL) or 15 (Cardiometabolic), with worked answers, for practice. Separate from the mid-term examination and the capstone project. | — |
Grading scale (European credit framework)
| Grade | Points |
|---|---|
| A · Excellent | 91–100 |
| B · Very good | 81–90 |
| C · Good | 71–80 |
| D · Satisfactory | 61–70 |
| E · Sufficient | 51–60 |
| FX · Not passed | 41–50 (one additional final assessment permitted) |
| F · Fail | 0–40 |
Key references
Every session is anchored to named, dated and externally verifiable sources. Links open in a new tab.
European policy and law
- European Commission. EU Cardiovascular Health Plan (Safe Hearts Plan). COM(2025) 1024, 16 December 2025.
- European Commission. Proposal for a Council Recommendation on cardiovascular health checks: an EU approach to early detection and screening. COM(2026) 481 final, 28 September 2026.
- Regulation (EU) 2024/1689 — Artificial Intelligence Act.
- Regulation (EU) 2025/327 — European Health Data Space.
- Regulation (EU) 2017/745 — medical devices.
- Regulation (EU) 2021/2282 — health technology assessment.
Clinical guidelines and consensus
- Køber L, et al. 2026 ESC Guidelines for the management of heart failure. Eur Heart J 2026.
- Damman K, et al. 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease. Eur Heart J 2026.
- Valabhji J, et al. Interventions for the prevention and management of cardiometabolic multiple long-term conditions. Lancet 2026;407:2668–2684.
- Kreutz R, et al. Cardiovascular-kidney-liver metabolic syndrome in primary care: a multidisciplinary consensus statement. Eur J Intern Med 2026;150:106902.
- SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms. Eur Heart J 2021;42:2439–2454.
- Visseren FLJ, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227–3337.
- McEvoy JW, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 2024;45:3912–4018.
- Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J 2020;41:111–188.
- 2025 Focused Update of the 2019 ESC/EAS dyslipidaemia guidelines. Eur Heart J 2025;46:4359–4378.
- Marx N, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J 2023;44:4043–4140.
- Ndumele CE, et al. 2026 AHA/ACC/ADA/ASN Guideline on Cardiovascular-Kidney-Metabolic Syndrome. Circulation 2026;154:e50–e158.
- NICE technology appraisal guidance TA1152: semaglutide in cardiovascular disease with overweight or obesity. May 2026.
Register your interest
Selecting a button opens a pre-addressed email to enquiry@mdacumen.com. Add your details and send; we will confirm eligibility, the enrolment route and any fees.
Need further details? Please visit our contact page, or write to enquiry@mdacumen.com.
Last editorial review: 10 October 2026 · Next scheduled refresh: 10 April 2027
© 2026 MD Acumen Ltd · Registered in England and Wales · Company no. 16538952 · ICO registration ZC105897